What is the incidence of chronic thromboembolic pulmonary hypertension (CTEPH) after multiple postoperative pulmonary emboli?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Incidence of CTEPH After Multiple Postoperative Pulmonary Emboli

The incidence of CTEPH after pulmonary embolism is approximately 3.8% at 2 years, with essentially all cases developing within the first 2 years after the initial PE event 1.

Key Incidence Data

The American Heart Association guidelines provide the most authoritative estimates based on prospective cohort data:

  • Cumulative 2-year incidence: 3.8% (approximately 1 in 25 patients with acute PE) 1
  • No cases developed beyond 2 years after the index PE event 1
  • Population-level incidence: 0.56% when including all PE patients (including early deaths) 2
  • Among PE survivors: 3.2% which is most relevant for clinical practice 2

Important Context for Multiple Emboli

Patients with recurrent PE face significantly higher risk - the odds ratio for developing CTEPH with subsequent pulmonary embolism is 3.17 (95% CI 2.02-4.96) 3. This means your postoperative patient with multiple emboli has approximately triple the baseline risk.

Critical Risk Factors to Identify

Beyond multiple emboli, watch for these high-risk features that substantially increase CTEPH likelihood:

  • Age >70 years: OR 2.04 3
  • Female gender: OR 1.44 3
  • COPD: OR 3.17 3
  • Heart failure: OR 2.52 3
  • Atrial fibrillation: OR 2.42 3
  • Unprovoked PE: OR 4.1 2

Surveillance Strategy

Obtain echocardiography at 6 weeks post-PE to predict subsequent CTEPH risk 1. Pulmonary artery pressures plateau at approximately 38 days after acute PE, making this the optimal screening window 1.

Echocardiographic Red Flags:

  • PA systolic pressure ≥40 mmHg at 1 year (75% of these patients required pulmonary endarterectomy within 5 years) 1
  • RV systolic dysfunction persisting beyond the acute phase 1

Common Pitfall

Up to 63% of patients diagnosed with CTEPH had no known prior PE 1, meaning the true population incidence may be higher than reported. In your postoperative patient with documented multiple emboli, maintain heightened vigilance even with adequate anticoagulation, as residual thrombus persists at 1 year in up to 50% of patients despite proper anticoagulation 1.

Clinical Implications for Postoperative Patients

Given the 3.8% baseline risk that triples with recurrent emboli, your patient with multiple postoperative PEs faces approximately 10-12% risk of developing CTEPH. This warrants:

  • Mandatory 6-week echocardiographic screening
  • Extended clinical surveillance for dyspnea and exercise intolerance
  • Low threshold for ventilation-perfusion scanning if symptoms develop
  • Referral to specialized CTEPH center if PA pressures remain elevated or symptoms persist

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.